Gabriel Doctor

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways

T. Alwyn Jones, Jennie N. Jeyapalan, Tim Forshew et al. · Acta Neuropathologica Communications · 2015 · 45 citations · Full text

DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas

Jennie N. Jeyapalan, Gabriel Doctor, T. Alwyn Jones et al. · Acta Neuropathologica Communications · 2016 · 20 citations · Full text

Tumour-specific Hypomethylation Signature, Epigenetic Change, Genetics +16

Quantifying variant contributions in cystic kidney disease using national-scale whole-genome sequencing

Omid Sadeghi‐Alavijeh, Melanie Chan, Gabriel Doctor et al. · Journal of Clinical Investigation · 2024 · 10 citations · Full text